Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis.
JHEP Rep
; 5(3): 100668, 2023 Mar.
Article
en En
| MEDLINE
| ID: mdl-36852108
ABM, Agence de la Biomédecine; BS, bariatric surgery; Bariatric surgery; CNI, calcineurin inhibitor; CST, corticosteroid; CV, cardiovascular; CYA, cyclosporine; ESLD, end-stage liver disease; HCC, hepatocellular carcinoma; LT, liver transplantation; MS, metabolic syndrome; NAFLD recurrence; NAFLD, non-alcoholic fatty liver disease; NASH; NASH, non-alcoholic steatohepatitis; liver transplantation; mTOR-i, mTOR inhibitor; metabolic syndrome
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
JHEP Rep
Año:
2023
Tipo del documento:
Article
País de afiliación:
Francia